Skip to main content
Xlife Sciences AG logo

Xlife Sciences AG — Investor Relations & Filings

Ticker · XLS ISIN · CH0461929603 LEI · 984500AH590BE88BB517 SW Professional, scientific and technical activities
Open in API
Filings indexed 287 across all filing types
Latest filing 2019-10-01 M&A Activity
Country CH Switzerland
Listing SW XLS

About Xlife Sciences AG

https://www.xlifesciences.ch/en/home

Xlife Sciences AG is a life sciences company that specializes in the value development and commercialization of early-stage research projects. The company identifies promising technologies from universities and other research institutions, acting as an incubator and accelerator to bridge the gap between academic research and healthcare markets. Its operations are focused on four core areas: technology platforms, biotechnologies and therapies, medical technology (health technology), and the application of artificial intelligence in life sciences and digital health. The primary objective is to develop solutions that address high unmet medical needs and improve quality of life.

Recent filings

Filing Released Lang Actions
Xlife Sciences AG: Xlife Sciences AG investiert in Hamburger Start-up
M&A Activity Classification · 1% confidence The document is a press release dated October 1, 2019, announcing that Xlife Sciences AG is investing in the AI start-up FUSE-AI GmbH. The content focuses on a strategic investment, synergy, and the development of a medical AI product (ProstateCarcinoma.ai). This type of announcement, detailing corporate investment and strategic moves, most closely aligns with a general corporate news release. Since there is no specific category for 'Investment Announcement' or 'Corporate News' that isn't already covered by a more specific filing (like M&A, Financing, or Director's Dealing), and given the nature of the announcement (a strategic investment in a new technology/company), it fits best under the general regulatory announcement fallback category, RNS, as it is distributed via DGAP (a service for regulatory news). It is not a formal financial report (10-K, IR, ER, MRQ) nor a specific transaction report (CAP, DIRS, POS).
2019-10-01 German
Xlife Sciences AG: Listing at Munich stock exchange
Regulatory Filings Classification · 1% confidence The document is a short press release dated September 30, 2019, announcing that Xlife Sciences AG shares are now listed on the Munich stock exchange (m:access). It details the location advantages and current share price. This is a specific corporate action related to the company's listing status, which is not explicitly covered by most specific codes like 10-K, ER, or DIV. It is not a standard financial report, an earnings call transcript, or a director's dealing. Since it is a specific announcement about market listing/trading status, and it doesn't fit perfectly into Capital/Financing Update (CAP) which usually implies fundraising or capital structure changes, the most appropriate general category for a specific, non-standard regulatory announcement disseminated via DGAP is the fallback category, Regulatory Filings (RNS). However, given the context of listing on an exchange, it is a significant corporate event announcement. If 'Listing Announcement' were an option, it would be preferred. Among the given options, RNS serves as the best fit for a general regulatory/market announcement not covered elsewhere.
2019-09-30 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.